https://www.selleckchem.com/pr....oducts/sch-900776.ht
nderstanding of upstream factors that predispose courses of critical care is needed. To assess the initial clinical experience with a novel endograft system (NEXUS Aortic Arch Stent Graft System) designed to treat aortic arch pathologies and address the morphology and hemodynamic challenges of the aortic arch. The aortic arch remains the most challenging part of the aorta for both open and endovascular repair. Transcatheter aortic arch repair has the potential to significantly reduce surgical risks. Patients underwent transcatheter a
Like
Comment
Share
